These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 12235005)
21. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311 [TBL] [Abstract][Full Text] [Related]
22. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor. Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116 [TBL] [Abstract][Full Text] [Related]
24. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
25. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202 [TBL] [Abstract][Full Text] [Related]
26. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208 [TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Liu B; Lee KW; Anzo M; Zhang B; Zi X; Tao Y; Shiry L; Pollak M; Lin S; Cohen P Oncogene; 2007 Mar; 26(12):1811-9. PubMed ID: 16983336 [TBL] [Abstract][Full Text] [Related]
30. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983 [TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Kong D; Okamura M; Yoshimi H; Yamori T Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Ito Y; Oike Y; Yasunaga K; Hamada K; Miyata K; Matsumoto S; Sugano S; Tanihara H; Masuho Y; Suda T Cancer Res; 2003 Oct; 63(20):6651-7. PubMed ID: 14583458 [TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic potency of vitamin E. Miyazawa T; Tsuzuki T; Nakagawa K; Igarashi M Ann N Y Acad Sci; 2004 Dec; 1031():401-4. PubMed ID: 15753181 [TBL] [Abstract][Full Text] [Related]
35. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities. Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822 [TBL] [Abstract][Full Text] [Related]
36. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization. Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719 [TBL] [Abstract][Full Text] [Related]
38. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Cao QZ; Lin ZB Acta Pharmacol Sin; 2004 Jun; 25(6):833-8. PubMed ID: 15169641 [TBL] [Abstract][Full Text] [Related]
39. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068 [TBL] [Abstract][Full Text] [Related]
40. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Veitonmäki N; Cao R; Wu LH; Moser TL; Li B; Pizzo SV; Zhivotovsky B; Cao Y Cancer Res; 2004 May; 64(10):3679-86. PubMed ID: 15150128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]